These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 4083937

  • 1. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies.
    Dahl LB, Dahl IM, Engström-Laurent A, Granath K.
    Ann Rheum Dis; 1985 Dec; 44(12):817-22. PubMed ID: 4083937
    [Abstract] [Full Text] [Related]

  • 2. Concentration and molecular weight distribution of hyaluronate in synovial fluid from clinically normal horses and horses with diseased joints.
    Tulamo RM, Heiskanen T, Salonen M.
    Am J Vet Res; 1994 May; 55(5):710-5. PubMed ID: 8067622
    [Abstract] [Full Text] [Related]

  • 3. Articular Joint Lubricants during Osteoarthritis and Rheumatoid Arthritis Display Altered Levels and Molecular Species.
    Kosinska MK, Ludwig TE, Liebisch G, Zhang R, Siebert HC, Wilhelm J, Kaesser U, Dettmeyer RB, Klein H, Ishaque B, Rickert M, Schmitz G, Schmidt TA, Steinmeyer J.
    PLoS One; 2015 May; 10(5):e0125192. PubMed ID: 25933137
    [Abstract] [Full Text] [Related]

  • 4. Hyaluronate and large molecular weight proteoglycans in synovial fluid from horses with various arthritides.
    Tulamo RM, Houttu J, Tupamäki A, Salonen M.
    Am J Vet Res; 1996 Jun; 57(6):932-7. PubMed ID: 8725825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals.
    Hutadilok N, Ghosh P, Brooks PM.
    Ann Rheum Dis; 1988 May; 47(5):377-85. PubMed ID: 2455485
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid.
    Punzi L, Schiavon F, Cavasin F, Ramonda R, Gambari PF, Todesco S.
    Clin Exp Rheumatol; 1989 May; 7(3):247-50. PubMed ID: 2547540
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?
    Aviad AD, Houpt JB.
    J Rheumatol; 1994 Feb; 21(2):297-301. PubMed ID: 8182640
    [Abstract] [Full Text] [Related]

  • 17. Assay of synovial fluid parameters: hyaluronan concentration as a potential marker for joint diseases.
    Praest BM, Greiling H, Kock R.
    Clin Chim Acta; 1997 Oct 31; 266(2):117-28. PubMed ID: 9437540
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.